vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与RBC Bearings INC（RBC）财务数据对比。点击上方公司名可切换其他公司
RBC Bearings INC的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.4倍（$461.6M vs $321.1M），RBC Bearings INC净利率更高（14.6% vs -18.2%，领先32.8%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 17.0%），RBC Bearings INC自由现金流更多（$99.1M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
该文本实际介绍的并非RBC Bearings，而是美国多佛公司。多佛是一家工业产品综合制造商，1955年成立，总部位于伊利诺伊州当纳斯格罗夫。2021年其业务分为五大板块：工程产品、清洁能源与加注、成像与识别、泵与工艺解决方案、气候与可持续技术，是标普500成分股，在纽约证券交易所上市。
MDGL vs RBC — 直观对比
营收规模更大
RBC
是对方的1.4倍
$321.1M
营收增速更快
MDGL
高出193.7%
17.0%
净利率更高
RBC
高出32.8%
-18.2%
自由现金流更多
RBC
多$232.9M
$-133.8M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $461.6M |
| 净利润 | $-58.6M | $67.4M |
| 毛利率 | — | 44.3% |
| 营业利润率 | -18.6% | 22.3% |
| 净利率 | -18.2% | 14.6% |
| 营收同比 | 210.8% | 17.0% |
| 净利润同比 | 1.4% | 16.4% |
| 每股收益（稀释后） | $-2.55 | $2.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLRBC
| Q4 25 | $321.1M | $461.6M | ||
| Q3 25 | $287.3M | $455.3M | ||
| Q2 25 | $212.8M | $436.0M | ||
| Q1 25 | $137.3M | $437.7M | ||
| Q4 24 | $103.3M | $394.4M | ||
| Q3 24 | $62.2M | $397.9M | ||
| Q2 24 | — | $406.3M | ||
| Q1 24 | $0 | $413.7M |
净利润MDGLRBC
| Q4 25 | $-58.6M | $67.4M | ||
| Q3 25 | $-114.2M | $60.0M | ||
| Q2 25 | $-42.3M | $68.5M | ||
| Q1 25 | $-73.2M | $72.7M | ||
| Q4 24 | $-59.4M | $57.9M | ||
| Q3 24 | $-107.0M | $54.2M | ||
| Q2 24 | — | $61.4M | ||
| Q1 24 | $-147.5M | — |
毛利率MDGLRBC
| Q4 25 | — | 44.3% | ||
| Q3 25 | — | 44.1% | ||
| Q2 25 | — | 44.8% | ||
| Q1 25 | 96.7% | 44.2% | ||
| Q4 24 | — | 44.3% | ||
| Q3 24 | — | 43.7% | ||
| Q2 24 | — | 45.3% | ||
| Q1 24 | — | 43.1% |
营业利润率MDGLRBC
| Q4 25 | -18.6% | 22.3% | ||
| Q3 25 | -39.7% | 21.5% | ||
| Q2 25 | -22.2% | 23.2% | ||
| Q1 25 | -57.8% | 23.0% | ||
| Q4 24 | -64.8% | 21.7% | ||
| Q3 24 | -187.1% | 21.6% | ||
| Q2 24 | — | 24.0% | ||
| Q1 24 | — | 22.8% |
净利率MDGLRBC
| Q4 25 | -18.2% | 14.6% | ||
| Q3 25 | -39.8% | 13.2% | ||
| Q2 25 | -19.9% | 15.7% | ||
| Q1 25 | -53.4% | 16.6% | ||
| Q4 24 | -57.5% | 14.7% | ||
| Q3 24 | -172.0% | 13.6% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | — |
每股收益（稀释后）MDGLRBC
| Q4 25 | $-2.55 | $2.13 | ||
| Q3 25 | $-5.08 | $1.90 | ||
| Q2 25 | $-1.90 | $2.17 | ||
| Q1 25 | $-3.32 | $2.33 | ||
| Q4 24 | $-2.50 | $1.82 | ||
| Q3 24 | $-4.92 | $1.65 | ||
| Q2 24 | — | $1.90 | ||
| Q1 24 | $-7.38 | $1.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $107.6M |
| 总债务越低越好 | $339.9M | $990.2M |
| 股东权益账面价值 | $602.7M | $3.3B |
| 总资产 | $1.3B | $5.1B |
| 负债/权益比越低杠杆越低 | 0.56× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资MDGLRBC
| Q4 25 | $198.7M | $107.6M | ||
| Q3 25 | $295.7M | $91.2M | ||
| Q2 25 | $186.2M | $132.9M | ||
| Q1 25 | $183.6M | $36.8M | ||
| Q4 24 | $100.0M | — | ||
| Q3 24 | $232.7M | — | ||
| Q2 24 | — | $76.8M | ||
| Q1 24 | $622.5M | $63.5M |
总债务MDGLRBC
| Q4 25 | $339.9M | $990.2M | ||
| Q3 25 | $339.8M | $1.1B | ||
| Q2 25 | $118.4M | $915.6M | ||
| Q1 25 | $118.0M | $920.1M | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | $1.2B |
股东权益MDGLRBC
| Q4 25 | $602.7M | $3.3B | ||
| Q3 25 | $625.7M | $3.2B | ||
| Q2 25 | $696.0M | $3.1B | ||
| Q1 25 | $710.6M | $3.0B | ||
| Q4 24 | $754.4M | $2.9B | ||
| Q3 24 | $777.2M | $2.9B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | $850.8M | $2.8B |
总资产MDGLRBC
| Q4 25 | $1.3B | $5.1B | ||
| Q3 25 | $1.4B | $5.1B | ||
| Q2 25 | $1.0B | $4.8B | ||
| Q1 25 | $996.6M | $4.7B | ||
| Q4 24 | $1.0B | $4.7B | ||
| Q3 24 | $1.1B | $4.7B | ||
| Q2 24 | — | $4.7B | ||
| Q1 24 | $1.1B | $4.7B |
负债/权益比MDGLRBC
| Q4 25 | 0.56× | 0.30× | ||
| Q3 25 | 0.54× | 0.34× | ||
| Q2 25 | 0.17× | 0.29× | ||
| Q1 25 | 0.17× | 0.30× | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $122.1M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $99.1M |
| 自由现金流率自由现金流/营收 | -41.7% | 21.5% |
| 资本支出强度资本支出/营收 | 0.1% | 5.0% |
| 现金转化率经营现金流/净利润 | — | 1.81× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDGLRBC
| Q4 25 | $-133.5M | $122.1M | ||
| Q3 25 | $79.8M | $88.4M | ||
| Q2 25 | $-47.1M | $120.0M | ||
| Q1 25 | $-88.9M | — | ||
| Q4 24 | $-104.5M | $84.0M | ||
| Q3 24 | $-67.0M | — | ||
| Q2 24 | — | $97.4M | ||
| Q1 24 | $-149.2M | — |
自由现金流MDGLRBC
| Q4 25 | $-133.8M | $99.1M | ||
| Q3 25 | $79.0M | $71.7M | ||
| Q2 25 | — | $104.3M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-104.7M | $73.6M | ||
| Q3 24 | $-67.8M | — | ||
| Q2 24 | — | $88.4M | ||
| Q1 24 | $-149.5M | — |
自由现金流率MDGLRBC
| Q4 25 | -41.7% | 21.5% | ||
| Q3 25 | 27.5% | 15.7% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | -101.3% | 18.7% | ||
| Q3 24 | -109.0% | — | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | — |
资本支出强度MDGLRBC
| Q4 25 | 0.1% | 5.0% | ||
| Q3 25 | 0.3% | 3.7% | ||
| Q2 25 | 0.0% | 3.6% | ||
| Q1 25 | 0.0% | 3.2% | ||
| Q4 24 | 0.2% | 2.6% | ||
| Q3 24 | 1.3% | 4.1% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | — |
现金转化率MDGLRBC
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 1.47× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.59× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
RBC
| Domestic | $413.3M | 90% |
| Foreign | $48.3M | 10% |
